Patents by Inventor Stephen F. Tuck

Stephen F. Tuck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CHIMERIC IMMUNOMODULATORY COMPOUNDS AND METHODS OF USING THE SAME-IV
    Publication number: 20150297737
    Abstract: The invention provides immunomodulatory compounds and methods for immunomodulation of individuals using the immunomodulatory compounds.
    Type: Application
    Filed: April 22, 2015
    Publication date: October 22, 2015
    Inventors: Karen L. FEARON, Dino Dina, Stephen F. Tuck
  • Chimeric immunomodulatory compounds and methods of using the same-IV
    Patent number: 9028845
    Abstract: The invention provides immunomodulatory compounds and methods for immunomodulation of individuals using the immunomodulatory compounds.
    Type: Grant
    Filed: September 18, 2013
    Date of Patent: May 12, 2015
    Assignee: Dynavax Technologies Corporation
    Inventors: Karen L. Fearon, Dino Dina, Stephen F. Tuck
  • CHIMERIC IMMUNOMODULATORY COMPOUNDS AND METHODS OF USING THE SAME-IV
    Publication number: 20140127255
    Abstract: The invention provides immunomodulatory compounds and methods for immunomodulation of individuals using the immunomodulatory compounds.
    Type: Application
    Filed: September 18, 2013
    Publication date: May 8, 2014
    Applicant: DYNAVAX TECHNOLOGIES CORPORATION
    Inventors: Karen L. FEARON, Dino DINA, Stephen F. TUCK
  • Chimeric immunomodulatory compounds and methods of using the same-IV
    Patent number: 8597665
    Abstract: The invention provides immunomodulatory compounds and methods for immunomodulation of individuals using the immunomodulatory compounds.
    Type: Grant
    Filed: January 12, 2012
    Date of Patent: December 3, 2013
    Assignee: Dynavax Technologies Corporation
    Inventors: Karen L. Fearon, Dino Dina, Stephen F. Tuck
  • Methods of modulating an immune response using immunostimulatory sequences and compositions for use therein
    Patent number: 8333980
    Abstract: The invention provides methods of modulating an immune response to a second antigen which entail administration of a first antigen and an immunostimulatory polynucleotide. Modulation of the immune response is generally manifested as stimulation of a Th1 response.
    Type: Grant
    Filed: November 13, 2008
    Date of Patent: December 18, 2012
    Assignee: Dynavax Technologies Corporation
    Inventors: Gary Van Nest, Stephen F. Tuck, Joseph Eiden, Jr.
  • CHIMERIC IMMUNOMODULATORY COMPOUNDS AND METHODS OF USING THE SAME-IV
    Publication number: 20120231039
    Abstract: The invention provides immunomodulatory compounds and methods for immunomodulation of individuals using the immunomodulatory compounds.
    Type: Application
    Filed: January 12, 2012
    Publication date: September 13, 2012
    Inventors: Karen L. FEARON, Dino Dina, Stephen F. Tuck
  • Chimeric immunomodulatory compounds and methods of using the same-II
    Patent number: 8222398
    Abstract: The invention provides immunomodulatory compounds and methods for immunomodulation of individuals using the immunomodulatory compounds.
    Type: Grant
    Filed: October 1, 2008
    Date of Patent: July 17, 2012
    Assignee: Dynavax Technologies Corporation
    Inventors: Karen L. Fearon, Dino Dina, Stephen F. Tuck
  • Biodegradable immunomodulatory formulations and methods for use thereof
    Patent number: 8124590
    Abstract: The invention provides new compositions and methods for immunomodulation of individuals. Immunomodulation is accomplished by administration of immunomodulatory polynucleotide/microcarrier (IMP/MC) complexes. The IMP/MC complexes may be covalently or non-covalently bound, and feature a polynucleotide comprising at least one immunostimulatory sequence bound to a biodegradable microcarrier or nanocarrier.
    Type: Grant
    Filed: June 19, 2007
    Date of Patent: February 28, 2012
    Assignee: Dynavax Technologies Corporation
    Inventors: Gary Van Nest, Stephen F. Tuck, Karen L. Fearon, Dino Dina
  • Chimeric immunomodulatory compounds and methods of using the same—IV
    Patent number: 8114418
    Abstract: The invention provides immunomodulatory compounds and methods for immunomodulation of individuals using the immunomodulatory compounds.
    Type: Grant
    Filed: October 30, 2006
    Date of Patent: February 14, 2012
    Assignee: Dynavax Technologies Corporation
    Inventors: Karen L. Fearon, Dino Dina, Stephen F. Tuck
  • Chimeric immunomodulatory compounds and methods of using the same
    Patent number: 8003115
    Abstract: The invention provides immunomodulatory compounds and methods for immunomodulation of individuals using the immunomodulatory compounds.
    Type: Grant
    Filed: August 10, 2007
    Date of Patent: August 23, 2011
    Assignee: Dynavax Technologies Corporation
    Inventors: Karen L. Fearon, Dino Dina, Stephen F. Tuck
  • Chimeric immunomodulatory compounds and methods of using the same—III
    Patent number: 7785610
    Abstract: The invention provides immunomodulatory compounds and methods for immunomodulation of individuals using the immunomodulatory compounds.
    Type: Grant
    Filed: December 23, 2002
    Date of Patent: August 31, 2010
    Assignee: Dynavax Technologies Corporation
    Inventors: Karen L. Fearon, Dino Dina, Stephen F. Tuck
  • Compositions comprising structurally stable conjugate molecules
    Patent number: 7718622
    Abstract: The present invention provides compositions comprising conjugate molecules that are structurally stable at a temperature of between about 2 degrees C. and 8 degrees C. In some examples, a conjugate molecule comprises an antigen, such as an allergen. In some examples, a conjugate molecule comprises the Ragweed antigen Amb a 1. The present invention provides methods for making and using such compositions. Provided herein are methods for modulating an immune response in an individual comprising administration of a composition comprising a structurally stable conjugate molecule as described herein.
    Type: Grant
    Filed: March 3, 2006
    Date of Patent: May 18, 2010
    Assignee: Dynavax Technologies Corporation
    Inventors: Stephen F. Tuck, Roberto Rodriguez
  • CHIMERIC IMMUNOMODULATORY COMPOUNDS AND METHODS OF USING THE SAME-II
    Publication number: 20090317480
    Abstract: The invention provides immunomodulatory compounds and methods for immunomodulation of individuals using the immunomodulatory compounds.
    Type: Application
    Filed: October 1, 2008
    Publication date: December 24, 2009
    Inventors: Karen L. Fearon, Dino Dina, Stephen F. Tuck
  • Immunomodulatory compositions containing an immunostimulatory sequence linked to antigen and methods of use thereof
    Patent number: 7628990
    Abstract: The invention provides classes of immunomodulatory compositions which comprise an average of one or more immunostimulatory sequence (ISS) containing polynucleotide conjugated, or attached, to antigen. The extent of conjugation affects immunomodulatory properties, such as extent of antigen-specific antibody form ration, including Th1-associated antibody formation, and thus these various conjugate classes are useful for modulating the type and extent of immune response. The invention also includes methods of modulating an immune response using these compositions.
    Type: Grant
    Filed: December 29, 2006
    Date of Patent: December 8, 2009
    Assignee: Dynavax Technologies Corporation
    Inventors: Stephen F. Tuck, Gary Van Nest
  • Chimeric immunomodulatory compounds and methods of using the same
    Publication number: 20080181909
    Abstract: The invention provides immunomodulatory compounds and methods for immunomodulation of individuals using the immunomodulatory compounds.
    Type: Application
    Filed: August 10, 2007
    Publication date: July 31, 2008
    Inventors: Karen L. Fearon, Dino Dina, Stephen F. Tuck
  • Chimeric immunomodulatory compounds and methods of using the same—I
    Patent number: 7255868
    Abstract: The invention provides immunomodulatory compounds and methods for immunomodulation of individuals using the immunomodulatory compounds.
    Type: Grant
    Filed: June 21, 2002
    Date of Patent: August 14, 2007
    Assignee: Dynavax Technologies Corporation
    Inventors: Karen L. Fearon, Dino Dina, Stephen F. Tuck
  • Chimeric immunomodulatory compounds and methods of using the same-IV
    Publication number: 20040132677
    Abstract: The invention provides immunomodulatory compounds and methods for immunomodulation of individuals using the immunomodulatory compounds.
    Type: Application
    Filed: July 18, 2003
    Publication date: July 8, 2004
    Inventors: Karen L. Fearon, Dino Dina, Stephen F. Tuck
  • Chimeric immunomodulatory compounds and methods of using the same - III
    Publication number: 20030225016
    Abstract: The invention provides immunomodulatory compounds and methods for immunomodulation of individuals using the immunomodulatory compounds.
    Type: Application
    Filed: December 23, 2002
    Publication date: December 4, 2003
    Inventors: Karen L. Fearon, Dino Dina, Stephen F. Tuck
  • Chimeric immunomodulatory compounds and methods of using the same - ll
    Publication number: 20030199466
    Abstract: The invention provides immunomodulatory compounds and methods for immunomodulation of individuals using the immunomodulatory compounds.
    Type: Application
    Filed: June 21, 2002
    Publication date: October 23, 2003
    Inventors: Karen L. Fearon, Dino Dina, Stephen F. Tuck
  • Compositions comprising structurally stable conjugate molecules
    Patent number: RE45196
    Abstract: The present invention provides compositions comprising conjugate molecules that are structurally stable at a temperature of between about 2 degrees C. and 8 degrees C. In some examples, a conjugate molecule comprises an antigen, such as an allergen. In some examples, a conjugate molecule comprises the Ragweed antigen Amb a 1. The present invention provides methods for making and using such compositions. Provided herein are methods for modulating an immune response in an individual comprising administration of a composition comprising a structurally stable conjugate molecule as described herein.
    Type: Grant
    Filed: May 18, 2012
    Date of Patent: October 14, 2014
    Assignee: Dynavax Technologies Corporation
    Inventors: Stephen F. Tuck, Roberto Rodriguez